NDA 18055, held by Abbott. Dextrose; Sodium Chloride.
As of Nov 14, 2026, NDA 18055 (Dextrose 3.3% And Sodium Chloride 0.3% In Plastic Container), held by Abbott, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Dextrose 3.3% And Sodium Chloride 0.3% In Plastic Container3.3GM/100ML;300MG/100ML ยท injectable;injection | Dextrose; Sodium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters